Dr. Leonidas Platanias, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago Medical Center

  Fellowship Hospital, 1992

• Kings County Hospital / Suny Downstate|suny Brooklyn

  Residency Hospital, 1989

• University Of Patras, School Of Health Sciences

  Medical School, 1983

• English

• German

• Greek

• Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110a inhibition, 2016-04-21

• Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma, 2020-06-16

• HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma, 2018-01-19

• Myeloid-derived suppressive cells promote B cell-mediated immunosuppression via transfer of PD-L1 in glioblastoma, 2019-09-17

• Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms, 2022-04-01

• Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors*, 2011-03-17

• Activation of the p38 Map Kinase Pathway is Essential for the Antileukemic Effects of Dasatinib, 2009-07-15

• IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma, 2018-03-02

• Alltransretinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma, 2010-05-09

• Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance, 2023-07-01

• Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias, 2015-09-07

• Dual Regulatory Roles of the Phosphatidylinositol 3-Kinase In Interferon Signaling1, 2008-11-15

• Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways, 2020-11-23

• Advances in the pharmacological management of acute myeloid leukemia in adults, 2022-09-07